Editorial Policies

Focus and Scope

International Journal of Basic Medical Sciences and Pharmacy (IJBMSP) is a scholarly peer reviewed international scientific journal published two times in a year, focusing on theories, methods, and applications in Medical sciences and Pharmacy. It provides a challenging forum for researchers, industrial professionals, managers, and policy makers working in the field to contribute and disseminate innovative new work. The journal provides a focal point for the publication of all aspects of research in the fields of Pharmaceutical, Medical, Biological, Biochemical, Biotechnological and Allied health Sciences. The journal publishes original research, reviews, short communication, case reports etc. All manuscripts will be subject to a well-established, fair, unbiased peer review and refereeing procedure, and are considered on the basis of their significance, novelty and usefulness to the Journals readership. The review output will be either accept or reject. A paper once rejected will not be considered again for review. The review process may take approximately 3-4 months to be completed. For accepted paper, should authors be requested by the editor to revise the text and minor changes, the revised version should be submitted within a month.

 

Section Policies

 

Peer Review Process

The review process may take approximately 3-4 months to be completed. For accepted paper, should authors be requested by the editor to revise the text and minor changes, the revised version should be submitted within a month.

 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

 

Editorial Board and Indexing/Abstracting

Editor in Chief Dr Abdul Wahab,

Department of Pharmacy, Kohat University of Science and Technology, Pakistan

Associate Editor Prof. Dr. Gul Majid Khan,

Department of Pharmacy,Quaid-e-Azam University, Pakistan

Ediorial Board

Ali Nokhodchi

Medway School of Pharmacy, The Universities of Kent and Greenwich, Central Ave., Anson Building, Kent ME4 4TB, UK

Dr.Simovska Pande Vera

Medical Faculty, University “St. Kiril and Metodij”, Skopje,Center of Sports Medicine, Nutrition Research UnitKrste Misirkov bb.1000 Skopje, Republic of Macedonia

Dr. Dionysios Douroumis

School of Science, Dept. Pharmaceutical Science Univeristy of Greenwich, Medway Campus, Central Avenue, Chatham Maritime, Kent, ME4 4AW

Dr.VIVIAN LEE

School of Pharmacy, Faculty of Medicine, Chinese University of Hong Kong

Dr.Nasser Ghaly Yousif

Department of surgery and inflammatory research, University of Colorado, School of Medicine, 12700 E.19th Ave,Aurora, CO 80247

Dr.Muralidhhar T.S

Dept of Biotechnology Dayananda Sagar College of biological Sciences, Shavige Malleshwara Hills. Kumaraswamy Layout. Bangalore- 560078.INDIA

Dr.Susmita Bagchi NYU Langone Medical Center, USA

Dr. T.S.N. Sankara Narayanan

Scientist E‐1 National Metallurgical Laboratory Madras Centre,CSIR Complex, Taramani Chennai‐600 113, India

Dr.Sarawut Kumphune Department of Medical Technology Faculty of Allied Health Sciences Naresuan University Thapoo, Meung Phitsanulok 65000, THAILAND

Dr. Abdul Waheed

Faculty of Health and Medical Sciences University of Surrey, Guildford, Surrey, UK

Dr. I. Anand Shaker

Department of Biochemistry Melmaruvathur Adhiparasakthi Institute of Medical Sciences, (MAPIMS) Melmaruvathur-603319, Chennai Tamil Nadu, INDIA.

Prof. Dr. Nisar-ur-Rahman

Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan

Dr. Hiba Alhamidi

Medway School of Pharmacy, The Universities of Kent and Greenwich, Central Ave., Anson Building, Kent ME4 4TB, UK

Prof. Dr. Jamshid Ali Bangash

Department of Pharmacy, peshawar University, Pakistan

Dr.Waseem Kaialy School of Pharmacy, Faculty of Science and Engineering, University of Wolverhampton Wolverhampton, WV1 1LY, UK

Dr. Kofi Asare-Addo

Medway School of Pharmacy, The Universities of Kent and Greenwich, Central Ave., Anson Building, Kent ME4 4TB, UK

prof. Dr. Abdullah Dayoo

Departmento of Pharmacy, University of Jamshoroo, Pakistan

Dr. Mughal Qayum Department of Pharmacy, Kohat University of Science and Technology, Pakistan

Dr.Marco E. Favretto

Radboud University Nijmegen Medical Centre Nijmegen, Centre for Molecular Life Sciences Biochemistry of integrated Systems, PO Box 9101, 6500 HB Nijmegen The Netherlands

Dr. Mohsen Sharifi

Division of Biochemical Toxicology, U.S. Food and Drug Administration Jefferson, AR, 72079, USA

DR. Abdul Rehman Quaid-e-Azam Medical College Bahawalpur, Pakistan

Dr. Jafar Khan, Department of Microbiology, Kohat University of Sciences and Technology, Kohat, KPK, Pakistan

Dr. Laila A. Abou Zeid
Faculty of Pharmacy, University of Mansoura,356116, Egyp

 

Dr. Asim Ahmed Elnour

Adjunct Clinical Associate Professor,

Pharmacology Department,Faculty of Medicine and Health Sciences (FMHS),United Arab Emirates University (UAEU)

 

Dr.Priyanka Chitranshi,
Food and Drug Administration (US-FDA)
National Center for Toxicological Research
HFT 233, 3900 NCTR Road
Jefferson, AR 72079, USA

 

Dr. Hamid Iqbal

Gwangju Institute of Science and Technology (GIST), Gwangju, Korea

 

Dr.Sara Ganaha

Brain Tumor Stem Cell Laboratory
Johns Hopkins University School of Medicine
Department of Neurosurgery
1550 Orleans St CRB II RM 272
Baltimore, MD 21231

 

................................................................................................................................................................................................................................................ Indexing/Abstracting ................................................................................................................................................................................................................................................ Ulrich's Periodical Directory DOAJ (Directory of Open Access journals) IndexCopernicus Open Academic Journals Index Directory of Research Journals Indexing J-Gate Geneva Foundation for Medical Education and Research CAS, A division of the American Chemical Society Science Central Google Scholar Open-J gate Scribd NewJour PSOAR and PGIAR Research Bible Necker OAJSE (Open Access Journals Search Engine) CiteFactor (Directory of International Research Journals) HINARI (United Nation's Database) EBSCOhost (USA) (Mail confirmation link) Pharmacy Dir WorldCat (The world's largest libray catalog) Toronto Public Library University of Wisconsin-Madison Libraries State Library of New South Wales, Australia Stanford University Libraries Stanford, California, USA Western Theological Seminary, Holand Open University of Malaysia library University of Saskatchewan Library, Canada Global Impact Factor Universal Impact Factor Scientific Journal Impact factor The Health Well AcademicKeys ResearchGate

 

Publication Ethics and Malpractice Statement

Publication Ethics and Malpractice Statement
The editors of International Journal of Basic Medical Sciences and Pharmacy (IJBMSP) are responsible for deciding which of the articles submitted to the journal should be published. In evaluating the submitted works, the editors should limit themselves only to the intellectual content. The editors should not be partial by matters such as race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors. The editors can choose to ignore any material that breaks legal requirements regarding libel, copyright infringement and plagiarism. The editors must ensure the confidentiality of the submitted works until they are published. The publication of an article in a peer-reviewed journal IJBMSP is an essential building block in the development of a logical and valued network of knowledge. It is a direct indication of the quality of the work of the authors and the institutions that support them. Peer-reviewed articles support and exemplify the scientific method. It is therefore important to agree upon standards of expected ethical behaviour for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, the publisher and the society.

Duties of authors
Reporting standards
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented correctly in the paper. A paper should contain sufficient detail and references to permit others to replicate the work.
Counterfeit or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Data access and retention
Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data, if feasible, and should in any event be prepared to retain such data for a reasonable time after publication.

Originality and plagiarism.
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted. Plagiarism takes many forms, from publishing of another‘s paper as the author‘s own paper, to copying or paraphrasing substantial parts of another‘s paper (without acknowledgment), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behaviour and is unacceptable.

Multiple, redundant or concurrent publication.
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is intolerable. In general, an author should not submit for consideration in another journal a previously published paper.

Acknowledgement of sources.
Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been significant in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.

Authorship of the paper.
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Hazards and human or animal subjects.
If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) has approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

Disclosure and conflicts of interest.
All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Fundamental errors in published works.
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author‘s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper. If the editor or the publisher learns from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

Duties of the Editorial Board.
These guidelines are based on existing Elsevier policies and COPE Best Practice Guidelines for Journal Editors.

Publication decisions.
The editor of a peer-reviewed journal IJBMSP is responsible for deciding which of the articles submitted to the journal should be published. The corroboration of the work in question and its importance to researchers and readers must always drive such decisions. The editor may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism.

Fair play.
An editor should evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.

Confidentiality.
The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

Disclosure and conflicts of interest.
Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Editors should recuse themselves (i.e. should ask a co-editor, associate editor or other member of the editorial board instead to review and consider) from considering manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or (possibly) institutions connected to the papers. Editors should require all contributors to disclose relevant competing interests and publish corrections if competing interests are revealed after publication. If needed, other appropriate action should be taken, such as the publication of a retraction or expression of concern.

Involvement and cooperation in investigations.
An editor should take reasonably responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper, in conjunction with the publisher (or society). Such measures will generally include contacting the author of the manuscript or paper and giving due consideration of the respective complaint or claims made, but may also include further communications to the relevant institutions and research bodies, and if the complaint is upheld, the publication of a correction, retraction, expression of concern, or other note, as may be relevant. Every reported act of unethical publishing behaviour must be looked into, even if it is discovered years after publication.



International Journal of Basic Medical Sciences and Pharmacy (IJBMSP): ISSN: 2049-4963